The normothermic preservation technology from EBERS was presented during the TERMIS-EU conference that took place on May 26-31 in Rhodes, Greece. The company was present with a stand in the commercial exhibition of the conference and, in addition, EBERS’ CEO presented participated with two posters in the scientific sessions of the conference.
 |
 |
 |
EBERS participated last May 24th in the HEALTH_LSR meeting that was held at the "Centro de Investigación Médica Avanzada" in Pamplona. Our CTO was talking about the advantages of normothermic perfusion applied to organs for transplantation. Around one hundred people assisted to the meeting, in which specialists of differen areas of engineering discussed about the application of innovative engineering techniques in medicine.
EBERS’ CEO, Pedro Moreo, participated in the EIC Innovators’ Forum organized in Berlin on September 10 by the European Innovation Council. He had the opportunity to exchange experiences with other beneficiaries from the SME Instrument program and presented the pitch deck of EBERS in a specific session for medical technology in front a jury of specialized investors.
 |
 |
EBERS’ CEO, Pedro Moreo, participated in the EIC-EVONIK Corporate Day that took place in the headquarters of Evonik in Essen on February 6, co-organized by the European Innovation Council and Evonik. It was a great opportunity to present the new organ preservation technology that EBERS is developing to representatives of the Health Care division and the corporate venture capital fund of Evonik and discuss about the technology and potential collaborations.
 |
|
 |
 |
Our CTO, Víctor Alastrué, was recently presenting EBERS's organ preservation project at Entrepreneurship day organized by ITAINNOVA.
